Gentlemen, For the sake of time and good manners amongst

New Post Public Reply Private Reply Replies (5) Message Board
TSOV Evil Rabbit #88487
626
Gentlemen,

For the sake of time and good manners amongst good people, PLEASE stop with this inane back and forth and back and forth again about NP, the FDA, BP, Dr. BP, conspiracies and everything and anything else of which actual shareholders at the moment have ZERO control.

The share price is down 22% in the last 5 days.

Let me repeat: down 22%.

In this time the ex-president of the Philippines has been released from the hospital (ICU) and is home resting comfortably AFTER being given LL, and this was AFTER being administered SOC which did absolutely ZERO for his improvement.

Concurrently, the positivity rate in India (the 2nd most populous nation in the WORLD) has surpassed 300,000 persons per day. The crematoriums there are no longer taking in the recently deceased as they are at capacity.

Brazil continues to spiral unabated and France is STILL locked down.

Let me repeat, the share price is down 22% in the last 5 days.

I have no idea what our CEO is doing. I have no idea what our Chairman and CMO is doing. However, I have a good idea of what they SHOULD BE DOING.

When over 1.3 BILLION people are at heightened risk for catching a virus for which there is no effective therapeutic once it progresses to severe/critical disease EXCEPT for the drug that the company of which you are CEO and CMO produces, I would expect ANY PRUDENT CEO and CMO to be pressing every button, pushing every and any lever and bending each knee to kiss whichever ring TO GET SAID DRUG OUT THE DOOR VIA A PURCHASE ORDER.

THAT is what CEOs and CMOs get paid millions of dollars per year in salary and bonus to actually DO!

I don't care about anything else. As a shareholder, that's what I (and all of you) pay the CEO and CMO to do: get the goddamn results!

All of this bantering about everything out of our control that neither the CEO or CMO can have immediate impact on is frivolous.

As shareholders we need to focus.
That focus should be applying MAXIMUM pressure on the CEO and CMO to GET RESULTS while 1.3 BILLION people are in dire need for our product. That is called not only Demand but Quantity Demand.

Most managament teams are lucky if they have even one of the above named two criteria in their market, that Cytodyn has BOTH simultaneously AND the share price is falling and has fallen 22% in 5 days is beyond ridiculous and tbvh, borders on incompetence.

I have nothing against NP or SK.
I expect results because THAT is what they are paid millions of dollars a year for.

Get the result or sell the company.

TSOV





3

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chery Auto's Bold Green Tech Showcase at 2026 Summit

Updated Category News Views 1

Chery Auto Puts Eco Tech at Front and Center You know, Chery Auto isn't just manufacturing cars anymore—it's shaping an entire lifestyle. For the uninitiated, they’re calling in everyone worth knowing to their headquarters in Wuhu, China, come October 18 through 24. The 2026 Chery International User Summit is kind of a big deal this year with nearly 20 new green...

Continue Reading
Shanghai's Arts Carnival Fuses Tech and Culture

Updated Category News Views 1

Shanghai Heralds New Era in Arts with Carnival Coming in hot, Shanghai's ready to shake up the city's cultural scene with the 2026 International Audio-Visual Arts Carnival. It's happening in Jing'an District from September 24 to October 18, promising an experience that fuses travel, technology, and art. Just about anyone can catch a break from their daily grind and dive...

Continue Reading
AI Agents Challenge Product Governance Models

Updated Category News Views 7

AI's Increasing Role: A Double-Edged Sword for Leaders Hey, the tech overlords remind us once again—the future doesn't wait for anyone to catch up before it bulldozes forward. Info-Tech Research Group has sounded the alarm on AI agents muscling their way into product decisions without any clear nod from the human corner office. Blurring Lines of Accountability The...

Continue Reading
Invictus Pharmacy Secures LegitScript Certification Status

Updated Category News Views 3

A New Chapter for Invictus Pharmacy In a world tangled up in red tape, Invictus Pharmacy somehow managed to cut a clear path by earning the LegitScript Healthcare Merchant Certification. Now, it seems like they've joined the ranks of the big players, including the likes of Amazon Pharmacy. It’s not just a shiny badge on their website, folks. It’s better access to...

Continue Reading
Beta Bionics Lawsuit Deadline: Investors Face November 3 Cut-off

Updated Category News Views 4

Looming Deadline for Beta Bionics Investors Time's ticking fast for those holding onto Beta Bionics (BBNX) stock who might've been caught in a web of undisclosed risks and regulatory misses. Investors feeling the pinch from this fiasco have till November 3, 2026, to throw their hat in the ring as lead plaintiffs in the class action lawsuit out of California. The...

Continue Reading
Xi Jinping Thought: A Bold Prospect for Future Governance

Updated Category News Views 5

107 years in the game, and the Communist Party of China (CPC) isn't showing any signs of slowing. With their recent conference in Beijing focusing on Xi Jinping Thought on Party Building, it’s clear they’ve got their eyes on the future, not just resting on past laurels. This Xi Jinping Thought is about a thorough self-improvement plan for the Party, a clear strategy...

Continue Reading
No Dogs Left Behind Marks Decade of Life-Saving Work

Updated Category News Views 4

A Decade of Dedication Some stories out there bring a much-needed shine to the otherwise relentless grind, and this is one of those rare gems. No Dogs Left Behind (NDLB) is celebrating a monumental milestone: ten years into their mission, they've crossed the incredible threshold of saving over 10,000 dogs from the clutches of slaughterhouses in East Asia. The nonprofit...

Continue Reading
Heafner Takes Helm at HGTC Amid Strategic Shifts

Updated Category News Views 2

A New Era for HGTC with Dr. Heafner at the Wheel Out of the frying pan and into the fire—Dr. Lori Heafner is stepping up to lead Horry-Georgetown Technical College (HGTC) with a clean slate and a hefty load of responsibility come January 2027. After enduring an intense national search by the Area Commission, she beat out tough competition to earn the role. It's not just...

Continue Reading
Kobold Press Explores Roleplaying as Literacy Tool

Updated Category News Views 5

Gaming Illuminates Pathways to Literacy and Community Trust me, when an indie game publisher like Kobold Press makes waves, it's worth paying attention. They've carved a niche in the roleplaying world by marrying traditional game elements with valuable educational tools. The thrill of the game goes beyond rolling dice; it's a ticket to improving literacy, arithmetic, and...

Continue Reading
China's Tech Success Echoes in Global Living Rooms

Updated Category News Views 2

A New Player in Global Tech If you've been sleeping on China's tech scene, it's time to wake up. Moonshot AI just launched Kimi K3, the largest open-source model by parameters we've seen, a significant leap in artificial intelligence that's catching even the eyes of folks who hardly touch technology—like retirees in Italy. Rapid AI Advancements China's story isn't about...

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating Crypto Investments Amid Global Turbulence

Updated Category News Views 160

The Impact of Global Events on Crypto Investments In today's fast-paced world, international conflicts can have immediate repercussions on global financial markets. Recent events in the Middle East have caused major fluctuations in traditional and digital currencies alike. As tensions rise, many investors seek safer havens for their assets, leading to increased interest...

Continue Reading
21Shares AG Unveils Supplementary Prospectus for Investors

Updated Category News Views 135

21Shares AG Announces Supplementary Prospectus 21Shares AG LEI: 254900UWHMJRRODS3Z64 Recently, 21Shares AG introduced a supplementary prospectus to their existing Base Prospectus. This supplement is an important update that reflects recent changes within the company's corporate structure, primarily due to their acquisition of 21co Holdings Limited by FalconX Group....

Continue Reading
Global Healthcare Cybersecurity Market Set to Soar by 2033

Updated Category News Views 193

The Growth of the Global Healthcare Cybersecurity Market The healthcare cybersecurity market is undergoing a major transformation. Initially estimated at USD 17.10 billion in 2023, it's on track to soar to USD 95.59 billion by 2033, reflecting a remarkable compound annual growth rate (CAGR) of 18.60%. This impressive growth is largely due to an alarming rise in...

Continue Reading
AVAV Stock: Analysts Bullish—But What's the Real Play?

Updated Category News Views 125

Analysts just cranked up their outlook on AeroVironment (AVAV), signaling a buy for the stock—but are they seeing something we’re missing? You know how these hype trains roll, right? Wall Street throws out ratings like confetti, but you gotta read between the lines. Let’s break down what this means for your wallet. AVAV Bullish Ratings: Surface-Level Optimism or...

Continue Reading
Renewal of Canadian Banc Corp's Equity Program Signals Growth

Updated Category News Views 142

Overview of the Renewed Equity Program Canadian Banc Corp. has recently announced the renewal of its at-the-market equity program (ATM Program), which allows the Company to issue shares to the public at its discretion. This program is effective until the specified period unless terminated earlier by the Company, focusing on executing strategic financial goals through...

Continue Reading